4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

Eva M.M. Strijbis; Jenny A. Nij Bijvank; Joep Killestein

doi:10.1177/1352458520923951

4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

Eva M.M. Strijbis^*
, Jenny A. Nij Bijvank
, Joep Killestein

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

3 Downloads (Pure)

Original language	English
Pages (from-to)	1309-1310
Number of pages	2
Journal	Multiple Sclerosis Journal
Volume	26
Issue number	11
DOIs	https://doi.org/10.1177/1352458520923951
Publication status	Published - 1 Oct 2020

Access to Document

10.1177/1352458520923951

4-aminopyridine-is-not-just-a-symptomatic-therapy-it-has-a-neuroprotective-effect--yes.pdfFinal published version, 85.4 KBLicence: CC BY

Cite this

@article{910033b8f2c04576b7e17f461b8d0012,

title = "4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes",

author = "Strijbis, \{Eva M.M.\} and \{Nij Bijvank\}, \{Jenny A.\} and Joep Killestein",

year = "2020",

month = oct,

day = "1",

doi = "10.1177/1352458520923951",

language = "English",

volume = "26",

pages = "1309--1310",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "11",

}

TY - JOUR

T1 - 4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

AU - Strijbis, Eva M.M.

AU - Nij Bijvank, Jenny A.

AU - Killestein, Joep

PY - 2020/10/1

Y1 - 2020/10/1

UR - https://www.scopus.com/pages/publications/85087551685

U2 - 10.1177/1352458520923951

DO - 10.1177/1352458520923951

M3 - Article

C2 - 32628062

AN - SCOPUS:85087551685

SN - 1352-4585

VL - 26

SP - 1309

EP - 1310

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - 11

ER -

4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

Access to Document

Other files and links

Cite this